Cargando…
Overview of Therapeutic Drug Monitoring
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687654/ https://www.ncbi.nlm.nih.gov/pubmed/19270474 http://dx.doi.org/10.3904/kjim.2009.24.1.1 |
_version_ | 1782167562087301120 |
---|---|
author | Kang, Ju-Seop Lee, Min-Ho |
author_facet | Kang, Ju-Seop Lee, Min-Ho |
author_sort | Kang, Ju-Seop |
collection | PubMed |
description | Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations. |
format | Text |
id | pubmed-2687654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | The Korean Association of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-26876542009-06-15 Overview of Therapeutic Drug Monitoring Kang, Ju-Seop Lee, Min-Ho Korean J Intern Med Review Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations. The Korean Association of Internal Medicine 2009-03 2009-03-06 /pmc/articles/PMC2687654/ /pubmed/19270474 http://dx.doi.org/10.3904/kjim.2009.24.1.1 Text en Copyright © 2009 The Korean Association of Internal Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Kang, Ju-Seop Lee, Min-Ho Overview of Therapeutic Drug Monitoring |
title | Overview of Therapeutic Drug Monitoring |
title_full | Overview of Therapeutic Drug Monitoring |
title_fullStr | Overview of Therapeutic Drug Monitoring |
title_full_unstemmed | Overview of Therapeutic Drug Monitoring |
title_short | Overview of Therapeutic Drug Monitoring |
title_sort | overview of therapeutic drug monitoring |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687654/ https://www.ncbi.nlm.nih.gov/pubmed/19270474 http://dx.doi.org/10.3904/kjim.2009.24.1.1 |
work_keys_str_mv | AT kangjuseop overviewoftherapeuticdrugmonitoring AT leeminho overviewoftherapeuticdrugmonitoring |